Features
Sort by: Newest first Oldest first A-Z Z-A
-
'Like a hug from everyone who loves you' — how MDMA could help patients with trauma Subscription
When combined with intensive psychotherapy sessions, MDMA — commonly known as ecstasy — has elicited impressive results in phase II trials and a global phase III study is just beginning.
-
Ten things pharmacists should know about biologics and biosimilars Subscription
As healthcare professionals prepare for blockbuster biologic Humira to come off patent on 16 October 2018, we highlight what pharmacists need to know about switching from originator biologics to biosimilars in order to get the best value from these medicines.
-
Why the 2018 flu season could be a major challenge for pharmacy Subscription
Despite the success pharmacy had in 2017 with offering influenza vaccination to people across the UK, winter 2018 is shaping up to be a difficult season, with different vaccines for different groups, staggered deliveries until December and guidance that makes patient prioritisation a problem.
-
Body bionics: how the next generation of biosensors could revolutionise drug delivery Subscription
Smaller, smarter and more sensitive — how four new technologies could change the way drugs are monitored and administered.
-
Are patients the missing piece in the drug development puzzle? Subscription
Pharmaceutical companies are beginning to appreciate that involving patients in the drug development life cycle could save them millions of pounds. But are companies being brave enough when it comes to ‘patient centricity’?
-
Stockpiles, shortages and supply chains: what a no-deal Brexit might mean for pharmacy Subscription
Fears of a no-deal Brexit impacting the UK’s drugs supply have been growing for some time, since the then health and social care secretary, Jeremy Hunt, admitted in January 2018 that the supply of some cancer drugs could be disrupted if the UK leaves the EU at the end of March 2019 with no agreement on a future relationship in place.
-
Preparing for the big biologic switch
With blockbuster biologic adalimumab coming off patent in October 2018, pharmacists should be ready to switch patients to the best-value biologic as alternatives become available.
-
Web therapy: how pharmacists are leading the way on telehealth Subscription
A solution developed to deliver clinical pharmacy services to remote dispensing GP practices in Scotland is being used as a model to expand telehealth services across the rest of NHS Highland.
-
Medical cannabis: what will pharmacy's role be? Subscription
How the UK has realised the benefits of medical cannabis and the involvement pharmacists could have in its supply.
-
Putting insomnia to bed Subscription
An estimated 30–50% of the population will experience insomnia symptoms at some point in their lives and, in the UK, insomnia rates steadily rise with age. With a 2% increase in sales of over-the-counter sleep aids during 2017, pharmacists are seeing more patients with insomnia symptoms. Here we discuss the health implications of not getting enough sleep and what can be done to help people drift off.
